MYELOSUPPRESSION

Clinical trials for MYELOSUPPRESSION explained in plain language.

Never miss a new study

Get alerted when new MYELOSUPPRESSION trials appear

Sign up with your email to follow new studies for MYELOSUPPRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New shot aims to shield cancer patients from dangerous chemo side effect

Disease control Recruiting now

This study is testing if a drug called mecapegfilgrastim can safely prevent a serious side effect of combined chemotherapy and radiation for chest cancers. The side effect, called myelosuppression, causes dangerously low white blood cell counts, increasing infection risk. Researc…

Matched conditions: MYELOSUPPRESSION

Phase: PHASE2 • Sponsor: Affiliated Hospital of Nantong University • Aim: Disease control

Last updated Mar 13, 2026 15:05 UTC

MYELOSUPPRESSION

Get alerted when new MYELOSUPPRESSION trials appear

New shot aims to shield cancer patients from dangerous chemo side effect